Cypherpunk Technologies Inc (CYPH) Stock Price, Quote & News

Company Profile

Cypherpunk Technologies Inc., a privacy technology company, implements a digital asset strategy anchored by Zcash in the United States. The company is involved in identifying, developing, investing in, acquiring, and building privacy-enhancing technologies; and accumulating digital assets, such as ZCash. It also develops biomarker-targeted antibody therapies for patients with cancer and other diseases comprising DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which has co...

Industry: Asset Management

Sector: Financial Services

Phone: 617 714 0360

Website: www.cypherpunk.com

Address:

47 Thorndike Street, Suite B1-1, Cambridge, United States

onlyLiveOnce Jul. 4 at 4:11 PM

$CYPH hot cliente trash 🚮 Same with $ZEC.X .. solves nothing and appears to be a wholesale pump and dump — good luck hodlers

0 · Reply

automaticstatic Jul. 3 at 1:52 AM

$GLXY hey I've been playing with $CYPH it's speculative as hell but not as bad as this POS scam

0 · Reply

StockDreamin Jul. 3 at 12:18 AM

$CYPH cyPHLAG

1 · Reply

GoGetDontGetGot Jul. 2 at 12:08 PM

$CYPH $ZEC

0 · Reply

hardrock2112 Jul. 1 at 2:37 PM

$CYPH Cantor Fitzgerald analyst Gareth Gacetta initiates coverage on Cypherpunk Technologies (NASDAQ:CYPH) with a Overweight rating and announces Price Target of $0.9. Write to Benzinga at [email protected]

1 · Reply

FamilyTime444 Jul. 1 at 2:10 PM

$CYPH hmm looking like maybe it wasn’t suppose to be under a $ ? 🐰

0 · Reply

atechniqueisause Jul. 1 at 2:09 PM

$CYPH Hey! I have an idea. How about we just jump to $5? ok?

1 · Reply

StockDreamin Jun. 30 at 8:28 PM

$CYPH $ZEC.X Im calling bullshit on that supposed security breach earlier in the month...another scam to manipulate!

0 · Reply

StockDreamin Jun. 30 at 8:02 PM

$CYPH cyPHECES

0 · Reply

atechniqueisause Jun. 29 at 8:31 PM

$CYPH Cy-fuhgeddaboudit! (have we done that one yet?)

0 · Reply

Cypherpunk Technologies initiated with an Overweight at Cantor Fitzgerald

Jun 18, 2026, 11:00 AM EDT - 16 days ago

Cypherpunk Technologies Transcript: AGM 2026

May 14, 2026, 7:05 AM EDT - 7 weeks ago

Cypherpunk Technologies Reports First Quarter 2026 Financial Results

May 14, 2026, 7:00 AM EDT - 7 weeks ago

Cypherpunk Technologies Quarterly report: Q1 2026

May 14, 2026, 7:00 AM EDT - 7 weeks ago

Cypherpunk Technologies Earnings release: Q1 2026

Apr 29, 2026, 8:00 AM EDT - 2 months ago

Cypherpunk Technologies Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

Cypherpunk Technologies Proxy statement: Proxy filing

2026-04-15T16:25:49.000Z - 2 months ago

Cypherpunk Technologies increases Zcash stake for $2.15M

Apr 15, 2026, 12:21 PM EDT - 2 months ago

Cypherpunk Increases its Zcash Stake, Launches New Website and Investor Dashboard

Mar 16, 2026, 4:50 PM EDT - 3 months ago

Cypherpunk Reports Full Year 2025 Financial Results

Mar 16, 2026, 4:00 PM EDT - 3 months ago

Cypherpunk Technologies Annual report: Q4 2025

Mar 16, 2026, 4:00 PM EDT - 3 months ago

Cypherpunk Technologies Earnings release: Q4 2025

Mar 9, 2026, 9:20 AM EDT - 4 months ago

Cypherpunk Makes $5M Investment into Zcash Open Development Lab (ZODL)

Jan 22, 2026, 7:00 AM EST - 5 months ago

Cypherpunk Adds Arjun Khemani as Strategic Advisor

2025-12-30T12:10:18.000Z - 6 months ago

Cypherpunk Technologies purchases additional $29M of ZEC

Dec 30, 2025, 7:00 AM EST - 6 months ago

Cypherpunk Accelerates Zcash Accumulation; Increases Treasury Holdings to 290,062.67 ZEC

Dec 19, 2025, 7:00 AM EST - 7 months ago

Josh Swihart, ECC CEO, Joins Cypherpunk as Strategic Advisor

Dec 15, 2025, 11:00 AM EST - 7 months ago

Cypherpunk Technologies Transcript: AGM 2025

Dec 9, 2025, 7:00 AM EST - 7 months ago

Cypherpunk Taps Zcash Founder Zooko as Strategic Advisor

Nov 19, 2025, 7:00 AM EST - 8 months ago

Cypherpunk Technologies Proxy statement: Proxy Filing

2025-11-18T12:21:34.000Z - 8 months ago

Cypherpunk Technologies purchases additional $18M of ZEC

Nov 12, 2025, 8:00 AM EST - 8 months ago

Cypherpunk Technologies (formerly Leap Therapeutics) Reports Third Quarter 2025 Financial Results

Nov 12, 2025, 7:00 AM EST - 8 months ago

Leap Therapeutics Rebrands as Cypherpunk; Expands Leadership Team to Drive New Zcash Treasury Strategy

Nov 12, 2025, 7:00 AM EST - 8 months ago

Cypherpunk Technologies Earnings release: Q3 2025

Nov 12, 2025, 7:00 AM EST - 8 months ago

Cypherpunk Technologies Quarterly report: Q3 2025

Nov 12, 2025, 7:00 AM EST - 8 months ago

Cypherpunk Technologies Proxy statement: Proxy Filing

Nov 3, 2025, 7:00 AM EST - 8 months ago

Cypherpunk Technologies Proxy statement: Proxy Filing

Nov 3, 2025, 7:00 AM EST - 8 months ago

Cypherpunk Technologies Proxy statement: Proxy Filing

Oct 24, 2025, 8:00 AM EDT - 9 months ago

Cypherpunk Technologies Proxy statement: Proxy Filing

Oct 20, 2025, 7:00 AM EDT - 9 months ago

Leap Therapeutics Presents Final Data from DeFianCe Study at ESMO 2025

Oct 9, 2025, 7:00 AM EDT - 9 months ago

Leap Therapeutics Announces Closing of $58.88 Million Private Placement in Cash Led by Winklevoss Capital to Initiate a Digital Asset Treasury Strategy

Oct 6, 2025, 9:00 AM EDT - 9 months ago

Leap Therapeutics Announces $58.88 Million Private Placement in Cash Commitments Led by Winklevoss Capital to Initiate a Digital Asset Treasury Strategy

Sep 25, 2025, 7:00 AM EDT - 10 months ago

Leap Therapeutics to Present Final Clinical Data from Part B of the DeFianCe Study at the ESMO Congress 2025

Aug 14, 2025, 7:00 AM EDT - 11 months ago

Leap Therapeutics Reports Second Quarter 2025 Financial Results

Aug 14, 2025, 7:00 AM EDT - 11 months ago

Cypherpunk Technologies Earnings release: Q2 2025

Aug 14, 2025, 7:00 AM EDT - 11 months ago

Cypherpunk Technologies Quarterly report: Q2 2025

Jun 23, 2025, 7:00 AM EDT - 1 year ago

Leap Therapeutics Reports Updated Clinical Data from Sirexatamab Colorectal Cancer Study and Announces Exploration of Strategic Alternatives

May 13, 2025, 9:30 AM EDT - 1 year ago

Cypherpunk Technologies Earnings release: Q1 2025

May 13, 2025, 9:30 AM EDT - 1 year ago

Cypherpunk Technologies Quarterly report: Q1 2025

May 13, 2025, 7:00 AM EDT - 1 year ago

Leap Therapeutics Reports First Quarter 2025 Financial Results

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Cypherpunk Technologies Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Cypherpunk Technologies Proxy statement: Proxy Filing

Apr 25, 2025, 1:00 PM EDT - 1 year ago

Leap Therapeutics to Present Preclinical Data of FL-501, a Novel GDF-15 Neutralizing Antibody, at the AACR 2025 Annual Meeting

Apr 23, 2025, 2:30 PM EDT - 1 year ago

Cypherpunk Technologies Transcript: Status Update

Apr 15, 2025, 7:00 AM EDT - 1 year ago

Leap Therapeutics to Host Virtual KOL Event to Discuss Sirexatamab (DKN-01) in Second-line Patients with Advanced Microsatellite Stable Colorectal Cancer

Mar 26, 2025, 7:05 AM EDT - 1 year ago

Leap Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 26, 2025, 7:00 AM EDT - 1 year ago

Leap Therapeutics Reports Positive Updated Data from Sirexatamab Colorectal Cancer Study

Mar 26, 2025, 7:00 AM EDT - 1 year ago

Cypherpunk Technologies Annual report: Q4 2024

Mar 26, 2025, 7:00 AM EDT - 1 year ago

Cypherpunk Technologies Earnings release: Q4 2024

Jan 28, 2025, 8:00 AM EST - 1 year ago

Cypherpunk Technologies Transcript: Study Result

Jan 28, 2025, 8:00 AM EST - 1 year ago

Cypherpunk Technologies Press release: Study Result

Jan 28, 2025, 8:00 AM EST - 1 year ago

Cypherpunk Technologies Slides: Study Result

Jan 28, 2025, 7:00 AM EST - 1 year ago

Leap Therapeutics Reports Initial Clinical Data from Part B of the DeFianCe Study and Part C of the DisTinGuish Study

Jan 15, 2025, 5:15 PM EST - 1 year ago

Cypherpunk Technologies Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 15, 2025, 5:15 PM EST - 1 year ago

Cypherpunk Technologies Slides: FY 2025

Jan 6, 2025, 7:00 AM EST - 1 year ago

Leap Therapeutics to Participate at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 4, 2024, 4:00 PM EST - 1 year ago

Cypherpunk Technologies Transcript: Piper Sandler 36th Annual Healthcare Conference

Nov 26, 2024, 7:00 AM EST - 1 year ago

Leap Therapeutics to Participate at Piper Sandler 36th Annual Healthcare Conference

Nov 13, 2024, 7:00 AM EST - 1 year ago

Leap Therapeutics Reports Third Quarter 2024 Financial Results

Nov 13, 2024, 6:30 AM EST - 1 year ago

Cypherpunk Technologies Earnings release: Q3 2024

Nov 13, 2024, 6:30 AM EST - 1 year ago

Cypherpunk Technologies Quarterly report: Q3 2024

Sep 30, 2024, 7:00 AM EDT - 1 year ago

Leap Therapeutics Announces Completion of Enrollment in Part B of the DeFianCe Study of DKN-01 for the Treatment of Colorectal Cancer Patients

Aug 12, 2024, 7:00 AM EDT - 2 years ago

Leap Therapeutics Reports Second Quarter 2024 Financial Results

Aug 12, 2024, 7:00 AM EDT - 2 years ago

Cypherpunk Technologies Quarterly report: Q2 2024

Aug 12, 2024, 7:00 AM EDT - 2 years ago

Cypherpunk Technologies Earnings release: Q2 2024

May 16, 2024, 8:00 AM EDT - 2 years ago

Cypherpunk Technologies Proxy statement: Proxy Filing

May 13, 2024, 7:00 AM EDT - 2 years ago

Leap Therapeutics Reports First Quarter 2024 Financial Results

May 13, 2024, 7:00 AM EDT - 2 years ago

Cypherpunk Technologies Quarterly report: Q1 2024

May 13, 2024, 7:00 AM EDT - 2 years ago

Cypherpunk Technologies Earnings release: Q1 2024

May 10, 2024, 8:00 AM EDT - 2 years ago

Cypherpunk Technologies Registration statement: Registration Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Cypherpunk Technologies Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Cypherpunk Technologies Proxy statement: Proxy Filing

Apr 11, 2024, 8:30 AM EDT - 2 years ago

Leap Therapeutics Announces $40 Million Private Placement

Mar 18, 2024, 8:00 AM EDT - 2 years ago

Cypherpunk Technologies Annual report: Q4 2023

Mar 18, 2024, 8:00 AM EDT - 2 years ago

Cypherpunk Technologies Earnings release: Q4 2023

Mar 18, 2024, 8:00 AM EDT - 2 years ago

Cypherpunk Technologies Registration statement: Registration Filing

Mar 18, 2024, 7:00 AM EDT - 2 years ago

Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

Jan 23, 2024, 8:30 AM EST - 2 years ago

Cypherpunk Technologies Transcript: Study Update

Jan 23, 2024, 8:30 AM EST - 2 years ago

Cypherpunk Technologies Press release: Study Update

Jan 23, 2024, 8:30 AM EST - 2 years ago

Cypherpunk Technologies Slides: Study Update

Jan 16, 2024, 5:05 PM EST - 2 years ago

Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium

Jan 10, 2024, 4:30 PM EST - 2 years ago

Cypherpunk Technologies Transcript: J.P. Morgan 42nd Annual Healthcare Conference 2024

Jan 10, 2024, 4:30 PM EST - 2 years ago

Cypherpunk Technologies Slides: FY 2024

Jan 3, 2024, 7:00 AM EST - 2 years ago

Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference

Jan 2, 2024, 7:00 AM EST - 2 years ago

Leap Therapeutics Announces Completion of Enrollment in Randomized Controlled Part C of the DisTinGuish Study of DKN-01 for the Treatment of Gastric Cancer Patients

Dec 11, 2023, 4:05 PM EST - 2 years ago

Leap Therapeutics to Present New Data from Part A of the DeFianCe Study of DKN-01 Plus Bevacizumab and Chemotherapy in Colorectal Cancer Patients at the 2024 ASCO Gastrointestinal Cancers Symposium

Nov 21, 2023, 7:00 AM EST - 2 years ago

Leap Therapeutics to Participate at Piper Sandler 35th Annual Healthcare Conference

Nov 13, 2023, 7:00 AM EST - 2 years ago

Leap Therapeutics Reports Third Quarter 2023 Financial Results

Nov 13, 2023, 7:00 AM EST - 2 years ago

Cypherpunk Technologies Quarterly report: Q3 2023

Sep 5, 2023, 7:00 AM EDT - 3 years ago

Leap Therapeutics to Participate at Upcoming Investor Conferences

Aug 14, 2023, 7:00 AM EDT - 3 years ago

Leap Therapeutics Reports Second Quarter 2023 Financial Results

Aug 14, 2023, 7:00 AM EDT - 3 years ago

Cypherpunk Technologies Quarterly report: Q2 2023

Aug 14, 2023, 7:00 AM EDT - 3 years ago

Cypherpunk Technologies Earnings release: Q2 2023

Jul 12, 2023, 7:00 AM EDT - 3 years ago

Leap Therapeutics Announces Initiation of Randomized Controlled Part B of the DeFianCe Study of DKN-01 in Colorectal Cancer Patients

Jun 20, 2023, 12:30 PM EDT - 3 years ago

Leap Therapeutics Announces Reverse Stock Split

Jun 9, 2023, 8:00 AM EDT - 3 years ago

Cypherpunk Technologies Registration statement: Registration Filing

May 25, 2023, 5:10 PM EDT - 3 years ago

Leap Therapeutics to Present Updated Data from Part A of the DisTinGuish Study of DKN-01 Plus Tislelizumab and Chemotherapy in Gastric Cancer Patients at the 2023 ASCO Annual Meeting

May 15, 2023, 7:00 AM EDT - 3 years ago

Leap Therapeutics Reports First Quarter 2023 Financial Results

May 15, 2023, 7:00 AM EDT - 3 years ago

Cypherpunk Technologies Quarterly report: Q1 2023

May 15, 2023, 7:00 AM EDT - 3 years ago

Cypherpunk Technologies Earnings release: Q1 2023

Apr 28, 2023, 8:00 AM EDT - 3 years ago

Cypherpunk Technologies Proxy statement: Proxy Filing

Apr 21, 2023, 8:00 AM EDT - 3 years ago

Cypherpunk Technologies Registration statement: Registration Filing

Apr 14, 2023, 8:00 AM EDT - 3 years ago

Cypherpunk Technologies Proxy statement: Proxy Filing

Apr 12, 2023, 7:00 AM EDT - 3 years ago

Leap Therapeutics Announces Completion of Enrollment in Part A of the DeFianCe Study of DKN-01 for the Treatment of Colorectal Cancer Patients

Mar 24, 2023, 8:00 AM EDT - 3 years ago

Cypherpunk Technologies Annual report: Q4 2022

Mar 24, 2023, 8:00 AM EDT - 3 years ago

Cypherpunk Technologies Earnings release: Q4 2022

Mar 24, 2023, 8:00 AM EDT - 3 years ago

Cypherpunk Technologies Proxy statement: Proxy Filing

Mar 24, 2023, 7:00 AM EDT - 3 years ago

Leap Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results

Mar 16, 2023, 4:05 PM EDT - 3 years ago

Leap Therapeutics Provides Update on BeiGene Option Agreement for DKN-01

Jan 23, 2023, 7:00 AM EST - 3 years ago

Cypherpunk Technologies Proxy statement: Proxy Filing

Jan 17, 2023, 9:00 AM EST - 3 years ago

Cypherpunk Technologies Transcript: M&A Announcement

Jan 17, 2023, 9:00 AM EST - 3 years ago

Cypherpunk Technologies Press release: M&A Announcement

Jan 17, 2023, 9:00 AM EST - 3 years ago

Cypherpunk Technologies Slides: M&A Announcement

Jan 17, 2023, 8:00 AM EST - 3 years ago

Leap Therapeutics Acquires Flame Biosciences

onlyLiveOnce Jul. 4 at 4:11 PM

$CYPH hot cliente trash 🚮 Same with $ZEC.X .. solves nothing and appears to be a wholesale pump and dump — good luck hodlers

0 · Reply

automaticstatic Jul. 3 at 1:52 AM

$GLXY hey I've been playing with $CYPH it's speculative as hell but not as bad as this POS scam

0 · Reply

StockDreamin Jul. 3 at 12:18 AM

$CYPH cyPHLAG

1 · Reply

GoGetDontGetGot Jul. 2 at 12:08 PM

$CYPH $ZEC

0 · Reply

hardrock2112 Jul. 1 at 2:37 PM

1 · Reply

FamilyTime444 Jul. 1 at 2:10 PM

$CYPH hmm looking like maybe it wasn’t suppose to be under a $ ? 🐰

0 · Reply

atechniqueisause Jul. 1 at 2:09 PM

$CYPH Hey! I have an idea. How about we just jump to $5? ok?

1 · Reply

StockDreamin Jun. 30 at 8:28 PM

$CYPH $ZEC.X Im calling bullshit on that supposed security breach earlier in the month...another scam to manipulate!

0 · Reply

StockDreamin Jun. 30 at 8:02 PM

$CYPH cyPHECES

0 · Reply

atechniqueisause Jun. 29 at 8:31 PM

$CYPH Cy-fuhgeddaboudit! (have we done that one yet?)

0 · Reply

DubLad76 Jun. 29 at 5:30 PM

$CYPH want to make some back? While we wait for this to improve? $ROLR, about to explode. just including in the Russell Microcap indicies and about to do official launch of its Prediction Markets website and mobile App. Investor meeting is tomorrow, 30th June. Think Polymarket or Kalshi just that its already listed and its CEO is known for building companies that deliver for investors. Super cheap even after today gains when conpared to Poly ir Kalshi. Not financial advice, always DYOR. $BTC.X investors, why not take a punt?

0 · Reply

StockDreamin Jun. 29 at 2:28 PM

$CYPH cyPHREE PHALLIN

0 · Reply

HK_Zhou Jun. 29 at 2:16 AM

$CYPH Massively underpriced compared to nav. Buy all the stock and sell zcash asset....

0 · Reply

StockDreamin Jun. 28 at 4:28 PM

$CYPH cyPHORTIES MONDAY

0 · Reply

StockDreamin Jun. 26 at 7:11 PM

$CYPH cyPHIREWORKS PHAIL

0 · Reply

StockDreamin Jun. 26 at 7:08 PM

$CYPH crappo markets last Friday of the 6th month....everyone redistributing and going on vacation

0 · Reply

DubLad76 Jun. 25 at 9:04 PM

$CYPH if the NAV is 0.87, why is thia 0.61?

0 · Reply

StockDreamin Jun. 25 at 6:52 PM

$CYPH we had our time...a chance to take some profit....may be years before we get there again

1 · Reply

Booker1 Jun. 25 at 6:12 PM

$CYPH We need ZEC to rally. I think we are close , but we need BTC to rally to move ZEC back towards $500.

0 · Reply

atechniqueisause Jun. 25 at 6:04 PM

$CYPH Ain't no cypher about it, just a straight up

0 · Reply

atechniqueisause Jun. 25 at 5:21 PM

$CYPH

0 · Reply

StockThingzs02 Jun. 25 at 4:09 PM

$CYPH .40’s the new 1$

0 · Reply

Market Cap	70.91M
Revenue (ttm)	0.00
Net Income (ttm)	4.82M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	2,142,300
Avg Vol	5,313,462
Day's Range	N/A - N/A
Shares Out	106.46M
Stochastic %K	45%
Beta	0.07
Analysts	Strong Sell
Price Target	$0.90